ERBB2 and breast cancer: At the protein level, there was no significant difference in ZSCAN18 expression between primary tumor and normal tissues (p = 0.606, > 0.05), but was much lower in the HER2-positive and TNBC subtypes than the luminal subtype of BC (p < 0.001) (Figures 1E, F).